Sang-Cheol Bae

Oct 1, 2024 | jrheum.org | Chang Guk Kim |Yeo Ju Kim |Seungsam Paik |Sang-Cheol Bae

Hemophagocytic lymphohistiocytosis (HLH) is characterized by excessive immune activation.1 It involves the activation of lymphocytes and histiocytes that infiltrate various organs and release cytokines.1A 60-year-old man presented with left hip swelling, heat sensation, tenderness, and fever. He had a history of recurrent fever, anemia, arthralgia, and inflammation at various sites, but no bacteria were found in tissue or blood samples.

Mar 21, 2024 | nature.com | Sang-Cheol Bae

AbstractThe strongest genetic risk factor for rheumatoid arthritis (RA) has been known as HLA-DRB1 based on amino acid positions 11, 71, and 74. This study analyzed the association between specific HLA-DRB1 locus and treatment response to abatacept or TNF inhibitors (TNFi) in patients with seropositive RA. A total of 374 Korean RA patients were treated with abatacept (n = 110) or TNFi (n = 264).

Mar 10, 2024 | jrheum.org | Yeo Ju Kim |Sang-Cheol Bae |Chang Guk Kim |Seungsam Paik

Thank you for your interest in spreading the word about The Journal of Rheumatology. NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas.

Oct 12, 2023 | ard.bmj.com | Joo-Young Lee |Arielle Mendel |Anca D. Askanase |Sang-Cheol Bae

Handling editor Josef S SmolenPresented at Prior conference presentation and published abstracts1. Lee JYE, Mendel A, Askanase A, Bae S, Buyon J et al. 'Systemic lupus erythematosus Women with lupus nephritis In pregnancy Therapeutic CHallenge (SWITCH)': The Systemic Lupus International Collaborating Clinics experience. American College of Rheumatology (ACR) Convergence 2022 – Philadelphia, PA, USA. 10–14 November 2022. Arthritis & Rheumatology.

Oct 5, 2023 | acrjournals.onlinelibrary.wiley.com | Tatsuya Atsumi |Sang-Cheol Bae |Hong Gu |Wen-Nan Huang

INTRODUCTION Pulmonary arterial hypertension (PAH) is a rare, progressive, and severe cardiopulmonary disorder (1). In patients with PAH, the small pulmonary arteries are obstructed because of cellular proliferation, fibrosis, and vascular remodeling, leading to premature death from right-sided heart failure (2-4).